FUSION PHARMACEUTICALS INC (FUSN)
CA36118A1003 - Common Stock
ChartMill assigns a Buy % Consensus number of 71% to FUSN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.1. This target is 3.46% above the current price.
FUSN was analyzed by 19 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about FUSN.
In the last month the buy percentage fell by 16 points. So the trust of analysts is decreasing.
FUSN was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-16 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-03-21 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-03-21 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-03-20 | JonesTrading | Downgrade | Buy -> Hold |
| 2024-03-20 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-03-20 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-03-20 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2024-03-20 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-03-19 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-03-19 | Brookline Capital | Downgrade | Buy -> Hold |
| 2024-03-19 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-03-19 | Wedbush | Downgrade | Outperform -> Neutral |
| 2024-03-19 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2024-03-19 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-03-19 | Jefferies | Downgrade | Buy -> Hold |
| 2024-03-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-26 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-01-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-05 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-12-27 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-12-27 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2023-12-20 | RBC Capital | Initiate | Outperform |
| 2023-10-03 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-09-29 | Oppenheimer | Initiate | Outperform |
| 2023-08-28 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-06-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-06-23 | Raymond James | Initiate | Outperform |
| 2023-03-30 | B. Riley Securities | Reiterate | Buy |
| 2023-01-27 | Morgan Stanley | Maintains | Overweight |
| 2022-12-01 | B. Riley Securities | Reiterate | Buy |